HealthCare Royalty Partners’ $150 Million Royalty Agreement with Karyopharm Therapeutics

Cadwalader advised HealthCare Royalty Partners on the transaction HealthCare Royalty Partners in connection with a revenue interest financing transaction with Karyopharm Therapeutics for up to $150...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here